Terms of Use
Effective date: June 1, 2026
1. Acceptance
By accessing novapharmanews.com (the "Site"), operated by NovaPharmaNews ("we," "us," or "our"), you agree to these Terms of Use. If you do not agree, do not use the Site.
2. Not medical or investment advice
Content on the Site is for informational and professional reference only. It does not constitute medical advice, diagnosis, treatment recommendations, or investment advice. Always consult qualified healthcare providers and licensed professionals for decisions about patient care or investments.
3. Intellectual property
Unless otherwise noted, editorial text, layout, branding, and original analysis on the Site are owned by NovaPharmaNews or its licensors. Entity data derived from public regulatory sources remains subject to the terms of those sources (see /about/data-sources).
You may link to our pages with proper attribution. Scraping, bulk republication, or automated extraction for commercial reuse without written permission is prohibited.
4. User conduct
You agree not to:
- Attempt unauthorized access to admin, API, or non-public areas
- Interfere with Site operation or security
- Submit false information through contact or subscription forms
- Use the Site in violation of applicable law
5. Third-party links
The Site links to external regulatory databases, journals, and partner sites. We are not responsible for third-party content or privacy practices.
6. Disclaimer of warranties
The Site and content are provided "as is" without warranties of any kind. While we strive for accuracy, we do not guarantee completeness, timeliness, or error-free content.
7. Limitation of liability
To the fullest extent permitted by law, NovaPharmaNews shall not be liable for indirect, incidental, or consequential damages arising from use of the Site or reliance on its content.
8. Changes
We may update these Terms. Continued use after changes constitutes acceptance. Material updates will be reflected on this page with a revised effective date.
9. Contact
Questions about these Terms: /us/contact. See also our Privacy Policy and Editorial Policy.